Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 2,601 shares at $4.60 ($12K) on 2009-06-18, disclosed to the SEC on 2009-06-19.
Scheduled sale ($12k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.76 | 1,201 | $6K | 47.0% |
| 2 | $4.60 | 1,400 | $6K | 53.0% |
| Total | $4.67 avg | 2,601 | $12K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |